BEAM vs DRI · rev $63.5M vs P/E 22, rev $12.08B
Beam Therapeutics Inc (BEAM) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
BEAM currently screens at market cap $2.01B. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the BEAM and DRI stock pages for the full models.
Not investment advice.